How to appeal a Horizon Blue Cross Blue Shield of New Jersey neurology — alzheimer's, parkinson's, als, epilepsy denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

Horizon Blue Cross Blue Shield of New Jersey-specific note: Only BCBS licensee in New Jersey; ~3.7M members. OMNIA Health Plans (tiered network) generate frequent appeals — tier-2 hospital usage carries higher cost share. NJ DOBI oversight; NJ has a strong external review program (IHCAP via Maximus).

What Horizon Blue Cross Blue Shield of New Jersey's policy requires for neurology — alzheimer's, parkinson's, als, epilepsy

Cited policy: Anthem BCBS BCBS medical policy — Deep Brain Stimulation

Bronstein 2011 criteria: >=4yr PD, levodopa-responsive, motor fluctuations/dyskinesia refractory to optimized medical therapy. Multidisciplinary eval (neurology + neurosurgery + neuropsych).

How Horizon Blue Cross Blue Shield of New Jersey denies neurology — alzheimer's, parkinson's, als, epilepsy — and how to counter it

Where Horizon Blue Cross Blue Shield of New Jersey pushes back: 1) Multidisciplinary eval missing; 2) 'Try optimized meds longer'; 3) Cognitive impairment concerns.

Counter-arguments that hold up: Submit complete multidisciplinary eval packet (Bronstein 2011 criteria documentation). Document optimized medical therapy trial (drug list + dose + duration). MoCA/MMSE within DBS-eligible range. Cite AAN PD Guidelines + MDS evidence review.

What Horizon Blue Cross Blue Shield of New Jersey typically denies for neurology — alzheimer's, parkinson's, als, epilepsy

Across Horizon Blue Cross Blue Shield of New Jersey's commercial and Medicare books, denials cluster around a small number of patterns. For neurology — alzheimer's, parkinson's, als, epilepsy, expect:

• OMNIA tier-1 vs tier-2 provider disputes
• Step therapy on biologics
• Behavioral health prior auth
• Out-of-state emergency reductions

Treatments most often denied in this category

These are the neurology — alzheimer's, parkinson's, als, epilepsy treatments most often flagged for prior auth, step therapy, or medical necessity review:

• Leqembi
• Kisunla
• Rytary / Crexont
• Ongentys / Gocovri
• Inbrija
• Onapgo

How to submit the appeal to Horizon Blue Cross Blue Shield of New Jersey

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document Horizon Blue Cross Blue Shield of New Jersey cited in the denial.
3. File the appeal through Horizon Blue Cross Blue Shield of New Jersey's portal (members: https://www.horizonblue.com ; providers: https://www.horizonblue.com/providers). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In NJ, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See Horizon Blue Cross Blue Shield of New Jersey's prior-authorization criteria by drug: Horizon Blue Cross Blue Shield of New Jersey PA criteria on ApprovalHelp.